Efficacy and Tolerability of Viloxazine Extended-Release for Attention-Deficit/Hyperactivity Disorder in Adolescents and Adults: A Systematic Review With Qualitative Synthesis of All Studies and Meta-Analysis of Adolescent Data
Viloxazine extended-release (ER) is a non-stimulant medication approved for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric and adult populations. While numerous randomized controlled trials (RCTs) have demonstrated its…
Suggested reading